Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by Smokey1958on Jun 30, 2021 9:46am
153 Views
Post# 33472498

RE:RE:Disappointing...

RE:RE:Disappointing...

While there are unique concerns taking place:

1. No interim financials by June 29th for the first time in 8 years.
2. No word yet on the 100,000 AcuVid test kits by today.

It would take a 1 million test kit order to match the DME Authority purchase agreement. As I mentioned yesterday and will add today Venowave is all over the DME website in spite of the fact they are distributors of other products. To have an initial purchase order of 5000 units and an obvious energy connected to that agreement is beyond significant.

Also, the fact that financials, AcuVid and the Venowave agreement have all converged at the same time has had THRM management burning the midnight candle. I'm not making excuses just proposing some rationale for the current situation.

GLTE .....holding patiently and purposefully. The rewards for that are starting to come to fruition!!!


mooseslayer wrote: I expect that it will be the next NR. It mentions they must meet test results...check... and that production levels are met and delivered during June 2021 That is the part we don't know. Did they produce and deliver the 100K units. The company really needs to give some guidance on final design of the product and production level capabilities and facilities.

 

<< Previous
Bullboard Posts
Next >>